Amebiasis

Infectious Agent

The protozoan parasite Entamoeba histolytica , possibly other Entamoeba spp.

Transmission

Fecal-oral route, either directly by person-to-person contact (such as by diaper-changing or sexual practices) or indirectly by eating or drinking fecally contaminated food or water.

Epidemiology

Amebiasis is distributed worldwide, particularly in the tropics, most commonly in areas of poor sanitation. Long-term travelers (duration >6 months) are significantly more likely than short-term travelers (duration <1 month) to develop E. histolytica infection. Immigrants and refugees from these areas are also at risk. People at higher risk for severe disease are those who are pregnant, immunocompromised, or receiving corticosteroids; associations with diabetes and alcohol use have also been reported.

Clinical Presentation

Most patients have a gradual illness onset days or weeks after infection. Symptoms include cramps, watery or bloody diarrhea, and weight loss and may last several weeks. Occasionally, the parasite may spread to other organs (extraintestinal amebiasis), most commonly the liver. Amebic liver abscesses may be asymptomatic, but most patients present with fever and right upper quadrant abdominal pain, usually in the absence of diarrhea.

Diagnosis

Microscopy does not distinguish between E. histolytica (known to be pathogenic), E. bangladeshi, E. dispar , and E. moshkovskii. E. dispar and E. moshkovskii have historically been considered nonpathogenic, but evidence is mounting that E. moshkovskii can cause illness; E. bangladeshi has only recently been identified, so its pathogenic potential is not well understood. More specific tests such as EIA or PCR are needed to confirm the diagnosis of E. histolytica . Additionally, serologic tests can help diagnose extraintestinal amebiasis.

Treatment

For symptomatic intestinal infection and extraintestinal disease, treatment with metronidazole or tinidazole should be followed by treatment with iodoquinol or paromomycin. Asymptomatic patients infected with E. histolytica should also be treated with iodoquinol or paromomycin, because they can infect others and because 4%–10% develop disease within a year if left untreated.

Prevention

Food and water precautions (see Chapter 2, Food & Water Precautions) and hand hygiene. Avoid fecal exposure during sexual activity.

CDC website: www.cdc.gov/parasites/amebiasis

Bibliography

  1. Choudhuri G, Rangan M. Amebic infection in humans. Indian J Gastroenterol. 2012 Jul;31(4):153–62.  [PMID:22903366]
  2. Cordel H, Prendki V, Madec Y, Houze S, Paris L, Bouree P, et al. Imported amoebic liver abscess in France. PLoS Negl Trop Dis. 2013;7(8):e2333.  [PMID:23951372]
  3. Heredia RD, Fonseca JA, Lopez MC.Entamoeba moshkovskii perspectives of a new agent to be considered in the diagnosis of amebiasis. Acta Trop. 2012 Sep;123(3):139–45.  [PMID:22664420]
  4. Lachish T, Wieder-Finesod A, Schwartz E. Amebic Liver Abscess in Israeli Travelers: A Retrospective Study. Am J Trop Med Hyg. 2016 May 4;94(5):1015–9.  [PMID:26928829]
  5. Shimokawa C, Kabir M, Taniuchi M, Mondal D, Kobayashi S, Ali IK, et al. Entamoeba moshkovskii is associated with diarrhea in infants and causes diarrhea and colitis in mice. J Infect Dis. 2012 Sep 1;206(5):744–51.  [PMID:22723640]
  6. Ximenez C, Moran P, Rojas L, Valadez A, Gomez A, Ramiro M, et al. Novelties on amoebiasis: a neglected tropical disease. J Glob Infect Dis. 2011 Apr;3(2):166–74.  [PMID:21731305]

Author

Jennifer R. Cope